India to United States: Voriconazole Export Trade Route
India has recorded 73 verified shipments of Voriconazole exported to United States, representing a combined trade value of $4.3M USD. This corridor is served by 15 active Indian exporters, with an average shipment value of $58.3K USD. The leading Indian exporter is GLAND PHARMA LTD, which accounts for 30% of total export value with 11 shipments worth $1.3M USD. On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer in United States with $968.4K USD in purchases. The top 3 suppliers — GLAND PHARMA LTD, AJANTA PHARMA LIMITED, SANDOZ PRIVATE LIMITED — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Voriconazole corridor is one of India's established pharmaceutical export routes, with 73 shipments documented worth a combined $4.3M USD. The route is dominated by GLAND PHARMA LTD, which alone accounts for roughly 30% of all export value, reflecting the consolidated nature of India's voriconazole manufacturing sector.
Across 15 active suppliers, the average shipment value stands at $58.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with voriconazole's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 14.9%, placing it at rank #16 among India's top voriconazole export destinations globally.
On the import side, key buyers of Indian voriconazole in United States include EVERSANA LIFE SCIENCE SERVICES, AJANTA PHARMA USA INC, Ajanta Pharma USA Inc C o RxCrossr and 22 others. EVERSANA LIFE SCIENCE SERVICES is the single largest importer with 12 shipments valued at $968.4K USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#16
- Annual growth+14.9%
- Demand growth+14.8%
- Regulatory ease79/100
Top 10 Indian Voriconazole Exporters to United States
Showing top 10 of 15 Indian suppliers exporting Voriconazole to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLAND PHARMA LTD Avg $114.3K per shipment | 11 | $1.3M | 29.5% |
| 2 | AJANTA PHARMA LIMITED Avg $64.2K per shipment | 18 | $1.2M | 27.1% |
| 3 | SANDOZ PRIVATE LIMITED Avg $62.7K per shipment | 9 | $563.9K | 13.2% |
| 4 | ZYDUS LIFESCIENCES LIMITED Avg $55.4K per shipment | 8 | $443.5K | 10.4% |
| 5 | GLAND PHARMA LIMITED Avg $137.4K per shipment | 3 | $412.1K | 9.7% |
| 6 | MYLAN LABORATORIES LIMITED Avg $65.2K per shipment | 4 | $260.9K | 6.1% |
| 7 | CADILA HEALTHCARE LIMITED Avg $75.0K per shipment | 2 | $149.9K | 3.5% |
| 8 | AUROLAB TRUST Avg $1.4K per shipment | 4 | $5.7K | 0.1% |
| 9 | ATLAS ENTERPRISES Avg $1.6K per shipment | 3 | $4.7K | 0.1% |
| 10 | AUROLAB Avg $1.7K per shipment | 1 | $1.7K | 0.0% |
This table shows the top 10 of 15 Indian companies exporting voriconazole to United States, ranked by total trade value. The listed exporters are: GLAND PHARMA LTD, AJANTA PHARMA LIMITED, SANDOZ PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED, GLAND PHARMA LIMITED, MYLAN LABORATORIES LIMITED, CADILA HEALTHCARE LIMITED, AUROLAB TRUST, ATLAS ENTERPRISES, AUROLAB. GLAND PHARMA LTD is the dominant supplier with 11 shipments worth $1.3M USD, giving it a 30% market share. The top 3 suppliers together account for 70% of the total trade value on this route.
Showing top 10 of 15 total Indian exporters on the India to United States Voriconazole export route.
Top 10 Voriconazole Importers in United States
Showing top 10 of 25 known buyers in United States receiving Voriconazole shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian voriconazole in United States include EVERSANA LIFE SCIENCE SERVICES, AJANTA PHARMA USA INC, Ajanta Pharma USA Inc C o RxCrossr, INTEGRATED COMMERCIALIZATION, SANDOZ INC C O EXEL INC, among 25 total buyers. The largest importer is EVERSANA LIFE SCIENCE SERVICES, accounting for $968.4K USD across 12 shipments — representing 23% of all voriconazole imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | 12 | $968.4K | 22.7% |
| 2 | AJANTA PHARMA USA INC | 5 | $397.1K | 9.3% |
| 3 | Ajanta Pharma USA Inc C o RxCrossr | 4 | $359.9K | 8.5% |
| 4 | INTEGRATED COMMERCIALIZATION | 4 | $318.1K | 7.5% |
| 5 | SANDOZ INC C O EXEL INC | 4 | $284.5K | 6.7% |
| 6 | MYLAN PHARMACEUTICALS INC | 4 | $260.9K | 6.1% |
| 7 | SANDOZ INC. C/O EXEL, INC. | 4 | $251.0K | 5.9% |
| 8 | ALMAJECT | 1 | $220.6K | 5.2% |
| 9 | AJANTA PHARMA USA INC. C/O RXCROSSR | 3 | $216.7K | 5.1% |
| 10 | FRESENIUS KABI USA LLC | 2 | $206.2K | 4.8% |
Showing top 10 of 25 Voriconazole importers in United States on this route.
Top 10 Voriconazole Formulations Imported by United States
Showing top 10 of 55 product formulations shipped on the India to United States Voriconazole route, ranked by trade value
United States imports a wide range of voriconazole formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — VORICONAZOLE FOR INJECTION 200MG/VIAL, 3 — accounts for $377.9K USD across 2 shipments. There are 55 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VORICONAZOLE FOR INJECTION 200MG/VIAL, 3 | 2 | $377.9K | 8.9% |
| 2 | VORICONAZOLE FOR INJECTION 200MG/VIAL, 3 | 2 | $363.2K | 8.5% |
| 3 | VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIAL | 4 | $220.4K | 5.2% |
| 4 | VORICONAZOLE TABLETS 200 MG 30BT TAB (PACKS 30S BOTTLE)(6192 PACKS X 30S=185760 NOS)NOS | 3 | $213.6K | 5.0% |
| 5 | VORICONAZOLE FOR INJECTION 200MG/VIAL 30ML VIAL LYOPHILIXED | 1 | $205.9K | 4.8% |
| 6 | VORICONAZOLE FOR INJECTION 200MG/VIAL 30ML VIAL | 1 | $172.1K | 4.0% |
| 7 | VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML VIAL (LYOPHILIZED) | 1 | $169.1K | 4.0% |
| 8 | VORICONAZOLE FOR INJECTION 200MG/VIAL, 30ML LYOVIALNOS | 3 | $160.9K | 3.8% |
| 9 | VORICONAZOLE TABLETS 200MG[10512PAC X 1X 30 = 315360 TABLETS] [EACH FILM COATEDTABLET CONTAINS:AS PER DOCUMENT | 1 | $152.5K | 3.6% |
| 10 | VORICONAZOLE TABLETS 200MG[10404PACx1X30=312120 TABLETS][EACH FILM COATED TABLETCONTAINS: VORICONAZOLE USP 200MG] | 1 | $150.3K | 3.5% |
Showing top 10 of 55 Voriconazole formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 76%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 13 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's voriconazole exports to United States are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LTD with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 15 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GLAND PHARMA LTD, AJANTA PHARMA LIMITED, SANDOZ PRIVATE LIMITED — together account for 70% of total trade value on this route. The average shipment value of $58.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as voriconazole for injection 200mg/vial, 3 and voriconazole for injection 200mg/vial, 30ml vial, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer with 12 shipments worth $968.4K USD — representing 23% of all voriconazole imports from India on this route. A total of 25 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.3M
- Avg. Shipment
- $58.3K
- Suppliers
- 15
- Buyers
- 25
- Transit (Sea)
- ~29 days
- Annual Growth
- +14.9%
Related Analysis
Reverse Direction
United States → India — Voriconazole (Import)Other Voriconazole Routes
Unlock the Full India to United States Voriconazole Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 73 shipments on this route.
Frequently Asked Questions — India to United States Voriconazole Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Voriconazole to United States?
The leading Indian exporters of Voriconazole to United States are GLAND PHARMA LTD, AJANTA PHARMA LIMITED, SANDOZ PRIVATE LIMITED. GLAND PHARMA LTD holds the largest market share at approximately 30% of total trade value on this route.
Q What is the total value of Voriconazole exports from India to United States?
India exports Voriconazole to United States worth approximately $4.3M USD across 73 recorded shipments. The average value per shipment is $58.3K USD.
Q Which ports does India use to ship Voriconazole to United States?
The most active port of origin is SAHAR AIR with 13 shipments. Indian exporters primarily use sea freight for this route, with 76% of shipments going by sea and 23% by air.
Q How long does shipping take from India to United States for Voriconazole?
The average transit time for Voriconazole shipments from India to United States is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Voriconazole trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 14.9% with demand growth tracking at 14.8%. The route is ranked #16 among India's top Voriconazole export destinations globally.
Q How many suppliers are active on the India to United States Voriconazole route?
There are currently 15 active Indian suppliers exporting Voriconazole to United States. The market is moderately concentrated with GLAND PHARMA LTD accounting for 30% of total shipment value.
Q Who are the main importers of Voriconazole from India in United States?
The leading importers of Indian Voriconazole in United States include EVERSANA LIFE SCIENCE SERVICES, AJANTA PHARMA USA INC, Ajanta Pharma USA Inc C o RxCrossr, INTEGRATED COMMERCIALIZATION, SANDOZ INC C O EXEL INC. EVERSANA LIFE SCIENCE SERVICES is the largest buyer with 12 shipments worth $968.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Voriconazole.
- 2.Supplier/Buyer Matching: 15 Indian exporters and 25 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 73 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
73 Verified Shipments
15 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists